简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-01-27 09:38 Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis
2021-01-26 15:08 Health Professionals Petition WHO for Guidance: People Should Use Nasal Sprays to Combat COVID-19 Pandemic; Doctors Use in Treating Patients
2021-01-25 18:07 BioBytes™ – Redefining How We Care for Our Health One Byte at a Time
2021-01-25 17:35 Takeda Named Global Top Employer for Fourth Consecutive Year
2021-01-22 10:20 ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
2021-01-21 13:10 Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA)
2021-01-20 15:30 ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets
2021-01-19 16:43 Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma
2021-01-15 15:41 Lars Lehne Appointed as Group CEO of Incubeta
2021-01-14 18:29 Asahi Kasei to Build a Second Plant for Ceolus™ Microcrystalline Cellulose
2021-01-14 11:40 Dr. Mike Durkin Assumes Role as Vice Chairman of Patient Safety Movement Foundation Board of Directors
2021-01-14 11:37 Rapid Medical Announces Appointment of James Romero as President, Americas
2021-01-14 11:34 Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-14 11:29 ARTMS and Telix Pharmaceuticals Announce Successful Production of PSMA-11 with Cyclotron Produced 68Ga from a Solid Target
2021-01-13 18:14 SETi and Seoul Viosys Violeds Technology Demonstrated to Kill 99% of Coronavirus (SARS-CoV-2) in Less Than a Second
2021-01-13 18:12 Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59
2021-01-13 18:07 Azbil Launches Early Warning System Software Globally
2021-01-13 16:47 iFit® Introduces Fitness Breakthrough: Personalized and Automatic Heart Rate Training with iFit ActivePulse™
2021-01-13 16:37 Oral-B’s Virtual Experience at 2021 Consumer Electronics Show Puts the Power to Control Health in Consumers’ Hands with the Oral-B iO™
2021-01-13 13:50 Clifford Siegel, Former Jefferies International CEO and Stifel Nicolaus Europe Vice-Chairman Joins Bryan, Garnier & Co as Non-Executive Chairman